157 related articles for article (PubMed ID: 36645109)
21. Endogenous intermedin protects against intimal hyperplasia by inhibiting endoplasmic reticulum stress.
Xue CD; Chen Y; Ren JL; Zhang LS; Liu X; Yu YR; Tang CS; Qi YF
Peptides; 2019 Nov; 121():170131. PubMed ID: 31408662
[TBL] [Abstract][Full Text] [Related]
22. Suv39h1 downregulation inhibits neointimal hyperplasia after vascular injury.
Zhang J; Chen J; Yang J; Xu C; Hu Q; Wu H; Cai W; Guo Q; Gao W; He C; Yang C; Yang J
Atherosclerosis; 2019 Sep; 288():76-84. PubMed ID: 31330382
[TBL] [Abstract][Full Text] [Related]
23. Extracellular Vesicles Derived from Adipose Mesenchymal Stem Cells Regulate the Phenotype of Smooth Muscle Cells to Limit Intimal Hyperplasia.
Liu R; Shen H; Ma J; Sun L; Wei M
Cardiovasc Drugs Ther; 2016 Apr; 30(2):111-8. PubMed ID: 26650931
[TBL] [Abstract][Full Text] [Related]
24. Myristoylated Alanine-Rich Protein Kinase Substrate (MARCKS) Regulates Small GTPase Rac1 and Cdc42 Activity and Is a Critical Mediator of Vascular Smooth Muscle Cell Migration in Intimal Hyperplasia Formation.
Yu D; Makkar G; Strickland DK; Blanpied TA; Stumpo DJ; Blackshear PJ; Sarkar R; Monahan TS
J Am Heart Assoc; 2015 Oct; 4(10):e002255. PubMed ID: 26450120
[TBL] [Abstract][Full Text] [Related]
25. Semaphorin-3E attenuates neointimal formation via suppressing VSMCs migration and proliferation.
Wu JH; Li Y; Zhou YF; Haslam J; Elvis ON; Mao L; Xia YP; Hu B
Cardiovasc Res; 2017 Dec; 113(14):1763-1775. PubMed ID: 29016743
[TBL] [Abstract][Full Text] [Related]
26. Role of PDE10A in vascular smooth muscle cell hyperplasia and pathological vascular remodelling.
Luo L; Cai Y; Zhang Y; Hsu CG; Korshunov VA; Long X; Knight PA; Berk BC; Yan C
Cardiovasc Res; 2022 Sep; 118(12):2703-2717. PubMed ID: 34550322
[TBL] [Abstract][Full Text] [Related]
27. BubR1 insufficiency inhibits neointimal hyperplasia through impaired vascular smooth muscle cell proliferation in mice.
Kyuragi R; Matsumoto T; Harada Y; Saito S; Onimaru M; Nakatsu Y; Tsuzuki T; Nomura M; Yonemitsu Y; Maehara Y
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):341-7. PubMed ID: 25524773
[TBL] [Abstract][Full Text] [Related]
28. Thrombospondin-4 ablation reduces macrophage recruitment in adipose tissue and neointima and suppresses injury-induced restenosis in mice.
Lv L; Liang W; Ye M; Zhang J; Zhang H; Xue G; Zhang L
Atherosclerosis; 2016 Apr; 247():70-7. PubMed ID: 26868511
[TBL] [Abstract][Full Text] [Related]
29. Targeted disruption of the prostaglandin E2 E-prostanoid 2 receptor exacerbates vascular neointimal formation in mice.
Zhu S; Xue R; Zhao P; Fan FL; Kong X; Zheng S; Han Q; Zhu Y; Wang N; Yang J; Guan Y
Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1739-47. PubMed ID: 21636806
[TBL] [Abstract][Full Text] [Related]
30. MTMR7 suppresses the phenotypic switching of vascular smooth muscle cell and vascular intimal hyperplasia after injury via regulating p62/mTORC1-mediated glucose metabolism.
Sun X; Yang Y; Zhao W; Wang M; Chen Y; Wang J; Yang D; Yang Y
Atherosclerosis; 2024 Mar; 390():117470. PubMed ID: 38342025
[TBL] [Abstract][Full Text] [Related]
31. Andrographolide inhibits the proliferation and migration of vascular smooth muscle cells via PI3K/AKT signaling pathway and amino acid metabolism to prevent intimal hyperplasia.
Han J; Tan C; Pan Y; Qu C; Wang Z; Wang S; Wang C; Xu K
Eur J Pharmacol; 2023 Nov; 959():176082. PubMed ID: 37783303
[TBL] [Abstract][Full Text] [Related]
32. Intraluminal Delivery of Simvastatin Attenuates Intimal Hyperplasia After Arterial Injury.
Helkin A; Bruch D; Wilson DR; Gruessner AC; Bader RR; Maier KG; Gahtan V
Vasc Endovascular Surg; 2019 Jul; 53(5):379-386. PubMed ID: 30982448
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of PIKfyve Ameliorates the Proliferation and Migration of Vascular Smooth Muscle Cells and Vascular Intima Hyperplasia By Reducing mTORC1 Activity.
Gu M; Wang Z; Feng F; Yang Y; Sun X; Yang D
J Cardiovasc Pharmacol; 2022 May; 79(5):739-748. PubMed ID: 35275098
[TBL] [Abstract][Full Text] [Related]
34. MIA SH3 Domain ER Export Factor 3 Deficiency Prevents Neointimal Formation by Restoring BAT-Like PVAT and Decreasing VSMC Proliferation and Migration.
Lei Y; Xu J; Li M; Meng T; Chen M; Yang Y; Li H; Zhuang T; Zuo J
Front Endocrinol (Lausanne); 2021; 12():748216. PubMed ID: 34858331
[TBL] [Abstract][Full Text] [Related]
35. Galangin inhibits neointima formation induced by vascular injury
Wu B; Xu C; Ding HS; Qiu L; Gao JX; Li M; Xiong Y; Xia H; Liu X
Food Funct; 2022 Nov; 13(23):12077-12092. PubMed ID: 36367287
[No Abstract] [Full Text] [Related]
36. Poldip2 knockdown inhibits vascular smooth muscle proliferation and neointima formation by regulating the expression of PCNA and p21.
Datla SR; L Hilenski L; Seidel-Rogol B; Dikalova AE; Harousseau M; Punkova L; Joseph G; Taylor WR; Lassègue B; Griendling KK
Lab Invest; 2019 Mar; 99(3):387-398. PubMed ID: 30237457
[TBL] [Abstract][Full Text] [Related]
37. Cyclooxygenase-2-derived prostaglandin E₂ promotes injury-induced vascular neointimal hyperplasia through the E-prostanoid 3 receptor.
Zhang J; Zou F; Tang J; Zhang Q; Gong Y; Wang Q; Shen Y; Xiong L; Breyer RM; Lazarus M; Funk CD; Yu Y
Circ Res; 2013 Jul; 113(2):104-14. PubMed ID: 23595951
[TBL] [Abstract][Full Text] [Related]
38. Nucleotide-binding oligomerization domain protein 2 deficiency enhances neointimal formation in response to vascular injury.
Kwon MY; Liu X; Lee SJ; Kang YH; Choi AM; Lee KU; Perrella MA; Chung SW
Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2441-7. PubMed ID: 21903945
[TBL] [Abstract][Full Text] [Related]
39. MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation.
Schlosser A; Pilecki B; Hemstra LE; Kejling K; Kristmannsdottir GB; Wulf-Johansson H; Moeller JB; Füchtbauer EM; Nielsen O; Kirketerp-Møller K; Dubey LK; Hansen PB; Stubbe J; Wrede C; Hegermann J; Ochs M; Rathkolb B; Schrewe A; Bekeredjian R; Wolf E; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Lindholt JS; Holmskov U; Sorensen GL
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):122-33. PubMed ID: 26564819
[TBL] [Abstract][Full Text] [Related]
40. PEA-15 (Phosphoprotein Enriched in Astrocytes 15) Is a Protective Mediator in the Vasculature and Is Regulated During Neointimal Hyperplasia.
Greig FH; Kennedy S; Gibson G; Ramos JW; Nixon GF
J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28893763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
